Skip to main content

Table 2 Molecular interactions present in the docked poses and the amino acids involved

From: Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties

SN

H bond

Bond length (Å) for H bond

C–H bond

Alkyl

Pi-alkyl

Pi-Pi

Pi-cation

Pi-sulfur/sigma

Halo-bond

28

CYS532

CYS532

ASP594

CYS532

2.43662

2.28681

2.80928

2.22688

ASP594

VAL502

LEU505

ILE527

LYS483

LEU505

ILE527

LYS483

LEU514

VAL471

ALA481

LEU514

CYS532

VAL471

TRP531

PHE583

PHE583

  

GLU501

N1

CYS532

CYS532

GLY596

CYS532

2.32682

2.28851

2.81173

2.25834

 

LYS483

VAL502

LEU505

ILE527

PHE468

PHE498

LEU505

LYS483

LEU514

VAL471

ALA481

LEU514

CYS532

VAL471

ALA481

TRP531

PHE583

PHE583

 

ILE527

GLU501

ASP594

N2

SER536

ASP594

ILE527

2.81389

1.5465

2.40925

SER535

GLY593

GLY534

 

VAL471

ALA481

CYS532

VAL471

ALA481

LYS483

LEU514

LYS483

LEU514

TRP531

LYS483

GLY534

 

N3

ASP594

PHE595

GLY596

GLY534

2.49798

2.78101

1.90411

2.04787

SER535

GLY593

ASP594

GLY596

HIS539

LEU505

ILE527

LYS483

ILE527

LYS483

LEU514

ALA481

CYS532

PHE583

LYS483

  

Vem

CYS532

GLY596

GLN530

1.69013

2.06126

1.74262

ASP594

GLY596

CYS532

THR529

LEU505

ILE527

PHE595

LYS483

ALA481

LEU514

CYS532

ALA481

CYS532

TRP531

PHE583

LYS483

 

ALA481

  1. H bond hydrogen bond, C–H bond carbon hydrogen bond, Halo-bond halogen bond